Click here to go to the previous page
Drug Shortages: Causes, Current State and Path Forward
Program Code:
339
Date:
Wednesday, June 26, 2013
Time:
10:15 AM to 11:45 AM
EST
CHAIR
:
Marta E. Wosinska, PhD (SCHAGY), Director for Economics Staff, Office of Planning and Analysis, CDER, FDA, United States
SPEAKER
(S):
Marta E. Wosinska, PhD (SPKAGY), Director for Economics Staff, Office of Planning and Analysis, CDER, FDA, United States
Christa Wirthumer-Hoche,
PhD (SPKAGY),
Member CMDh, Head of Institute, Deputy Head of Austrian Medicines and Medical Devices Agency (AGES), Austria
Christa Wirthumer-Hoche studied biochemistry TU Vienna, doctoral thesis at Medical Physiology. Starting at the AT Nat. Inst. for Quality Control of Drugs - quality assessment, Head of Regulatory Affairs in the Ministry of Health, Now Head of Licensing of Med Products and Deputy Head of the Austrian
|
Erin Fox,
PharmD (SPKSUP), Director, Drug Information Service,
University of Utah Hospitals and Clinics, United States
Erin directs the University of Utah Health Care Drug Information Service (UUDIS) and is adjunct associate professor at the UU College of Pharmacy. The UUDIS provides drug shortage content for the American Society of Health-System Pharmacists. Erin is recognized as an expert in drug shortages.
|
Description
This forum will discuss the history and current state of drug shortages. It will primarily focus on the drivers and consequences of manufacturing quality problems for sterile injectable products.